REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/27/2025
Back to search
Official data from USPTO
TIZONA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TIZONA THERAPEUTICS
ST13
US500000086984567Class
42
Filing
86984567
Registration
6185401
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
63
Latest update
10/28/2025
Trademark type
Word
Nice classes
42
Filing date
06/10/2015
Registration date
10/27/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/27/2020
Last transaction
10/28/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/16/2016
First use in commerce
05/16/2016
Drawing code
4
Owner type
03
Owner location
South San Francisco, CA
Examiner
MAHONEY,PAULA M
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
TIZONA THERAPEUTICS, INC.
Vesuvius Pharmaceuticals, Inc.
Representatives
Sharon Smith Morgan, Lewis & Bockius LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of pharmaceuticals and compounds for the treatment of cancer and autoimmune diseases; research and development of pharmaceuticals and compounds for modulation of the immune system and the tumor microenvironment
Publications
History of USPTO decisions and trademark events.
63 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/27/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/25/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/24/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
09/24/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/24/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
09/24/2020
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
09/24/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/27/2020
GNRT
NON-FINAL ACTION E-MAILED
07/27/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
07/27/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/24/2020
DPCC
DIVISIONAL PROCESSING COMPLETE
06/24/2020
DRRR
DIVISIONAL REQUEST RECEIVED
01/31/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/11/2019
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
02/05/2019
IUAF
USE AMENDMENT FILED
01/31/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/31/2019
EISU
TEAS STATEMENT OF USE RECEIVED
01/31/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/09/2018
EX5G
SOU EXTENSION 5 GRANTED
08/08/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/08/2018
EXT5
SOU EXTENSION 5 FILED
08/01/2018
EEXT
SOU TEAS EXTENSION RECEIVED
08/01/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/02/2018
EX4G
SOU EXTENSION 4 GRANTED
01/31/2018
EXT4
SOU EXTENSION 4 FILED
01/31/2018
EEXT
SOU TEAS EXTENSION RECEIVED
01/31/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/04/2017
EX3G
SOU EXTENSION 3 GRANTED
08/02/2017
EXT3
SOU EXTENSION 3 FILED
08/02/2017
EEXT
SOU TEAS EXTENSION RECEIVED
08/02/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/17/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/17/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/16/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/16/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/17/2016
EX2G
SOU EXTENSION 2 GRANTED
12/15/2016
EXT2
SOU EXTENSION 2 FILED
12/15/2016
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/01/2016
EX1G
SOU EXTENSION 1 GRANTED
06/29/2016
EXT1
SOU EXTENSION 1 FILED
06/29/2016
EEXT
SOU TEAS EXTENSION RECEIVED
06/29/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/29/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/02/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/13/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/08/2015
PUBO
PUBLISHED FOR OPPOSITION
12/08/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/18/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/04/2015
ALIE
ASSIGNED TO LIE
11/04/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
09/26/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/26/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
09/26/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/26/2015
DOCK
ASSIGNED TO EXAMINER
09/19/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/15/2015
NWAP
NEW APPLICATION ENTERED
06/13/2015
Continuous trademark protection
Get notified about every new filing that threatens TIZONA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.